Psoriasis Longitudinal Assessment and Registry(English)

• psoriasis patients with self-reported PsA in the TNF inhibitors, infliximab, adalimumab, etanercept, and MTX cohorts have numerically higher SI rates than the ustekinumab cohort, although not statistically significant. Age, history of infection, and diabetes are associated with an increased risk for SI, irrespective of biologic exposure
• PsA, MTX, SI, TNF
• Dermatology, Risk factor
• https://doi.org…1927-019-0094-3